Program

[Part I] Moderator: Dr. Chang-Tsu Yuan

{to be announced}.

[Part II] Moderator: Prof. Siok-Bian Ng

{to be announced}.

[Featured lecture part I]

History and future prospect of Lymphoma Study in Asia

Shigeo Nakamura, Nagoya University, Nagoya, Japan

Bone marrow pathology beyond cytology, not new but: focusing on MDS and MPN diagnosis.

Masafumi Ito, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, Nagoya, Japan

The Elusive Blastic Plasmacytoid Dendritic Cell Neoplasm: Diagnostic Pitfalls and Molecular Insights

Kengo Takeuchi, Japanese Foundation for Cancer Research, Tokyo, Japan

[Featured lecture part II]

When Diagnosis Impacts Therapy: Why Lymphoma Classification Matters

Tai-Chung Huang, National Taiwan University Hospital, Taipei, Taiwan

Mimics and Misdiagnosis: Navigating the Challenges in Mantle Cell Lymphoma

Wen-Yu Chuang, Cathay General Hospital, Taipei, Taiwan

Adult T-cell Leukemia/Lymphoma: How Not to Miss It

Kennosuke Karube, Nagoya University, Nagoya, Japan

The clinicopathological spectrum of intestinal T or NK-cell lymphoproliferative disorders

Shih-Sung Chuang, Chi-Mei Medical Center, Tainan, Taiwan

[Featured lecture part III]

Genetic subtypes of Korean diffuse large B-cell lymphoma using clinical NGS panel.

Yoon Kyung Jeon, Seoul National University, Seoul, Korea

EBV-positive nodal T- and NK-cell lymphoma: Updates in Pathogenesis and Practical Approaches to Differential Diagnosis

Siok Bian Ng, National University of Singapore, Singapore, Singapore

Multicenter clinical studies of lymphoma in Japan: NK/T-cell lymphoma and DLBCL

Motoko Yamaguchi, Mie University, Tsu, Japan

[Lunch Seminars Sponsored by BeOne] Moderator: Prof. Shih-Sung Chuang

Unraveling the Spectrum of Idiopathic Multicentric Castleman Disease: Histologic Subtypes and Diagnostic Pitfalls.

Midori Filiz Nishimura, Okayama University, Okayama, Japan

[Lunch Seminars Sponsored by Takeda] Moderator: Prof. Kennosuke Karube

Peripheral T-Cell Lymphoma: Pathologic Classification and Therapeutic Implications of CD30 Expression.

Wen-Yu Chuang, Cathay General Hospital, Taipei, Taiwan